Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)
$3.4000
-0.1300 ( -2.30% ) 631.5K
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.
Market Data
Open
$3.4000
Previous close
$3.5300
Volume
631.5K
Market cap
$227.77M
Day range
$3.3150 - $3.5280
52 week range
$2.7000 - $19.0500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 17 | May 29, 2024 |
8-k | 8K-related | 13 | May 20, 2024 |
10-q | Quarterly Reports | 75 | May 15, 2024 |
8-k | 8K-related | 13 | May 15, 2024 |
4 | Insider transactions | 1 | Apr 24, 2024 |
def | Proxies and info statements | 5 | Apr 18, 2024 |
8-k | 8K-related | 12 | Apr 16, 2024 |
pre | Proxies and info statements | 5 | Apr 08, 2024 |
8-k | 8K-related | 12 | Apr 08, 2024 |
8-k | 8K-related | 15 | Apr 03, 2024 |